Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast

被引:84
作者
Gomes, Douglas S. [1 ]
Porto, Simone S. [1 ]
Balabram, Debora [1 ]
Gobbi, Helenice [1 ]
机构
[1] Fed Univ Minas Gerais UFMG, Sch Med, Breast Pathol Lab, BR-30130100 Belo Horizonte, MG, Brazil
关键词
Breast cancer; Lobular neoplasia; Columnar cell lesions; Atypical ductal hyperplasia; Ductal carcinoma in situ; Inter-observer variability; Agreement; E-CADHERIN; REPRODUCIBILITY; BIOPSIES; CANCER; RISK; MORPHOLOGY; FREQUENCY;
D O I
10.1186/1746-1596-9-121
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: This study aimed to assess inter-observer variability between the original diagnostic reports and later review by a specialist in breast pathology considering lobular neoplasias (LN), columnar cell lesions (CCL), atypical ductal hyperplasia (ADH), and ductal carcinoma in situ (DCIS) of the breast. Methods: A retrospective, observational, cross-sectional study was conducted. A total of 610 breast specimens that had been formally sent for consultation and/or second opinions to the Breast Pathology Laboratory of Federal University of Minas Gerais were analysed between January 2005 and December 2010. The inter-observer variability between the original report and later review was compared regarding the diagnoses of LN, CCL, ADH, and DCIS. Statistical analyses were conducted using the Kappa index. Results: Weak correlations were observed for the diagnoses of columnar cell change (CCC; Kappa = 0.38), columnar cell hyperplasia (CCH; Kappa = 0.32), while a moderate agreement (Kappa = 0.47) was observed for the diagnoses of flat epithelial atypia (FEA). Good agreement was observed in the diagnoses of atypical lobular hyperplasia (ALH; Kappa = 0.62) and lobular carcinoma in situ (LCIS; Kappa = 0.66). However, poor agreement was observed for the diagnoses of pleomorphic LCIS (Kappa = 0.22). Moderate agreement was observed for the diagnoses of ADH (Kappa = 0.44), low-grade DCIS (Kappa = 0.47), intermediate-grade DCIS (Kappa = 0.45), and DCIS with microinvasion (Kappa = 0.56). Good agreement was observed between the diagnoses of high-grade DCIS (Kappa = 0.68). Conclusions: According to our data, the best diagnostic agreements were observed for high-grade DCIS, ALH, and LCIS. CCL without atypia and pleomorphic LCIS had the worst agreement indices.
引用
收藏
页数:9
相关论文
共 38 条
[1]   High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma [J].
Abdel-Fatah, Tarek M. A. ;
Powe, Desmond G. ;
Hodi, Zsolt ;
Lee, Andrew H. S. ;
Reis-Filho, Jorge S. ;
Ellis, Ian O. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (03) :417-426
[2]   Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions [J].
Andrade, Victor P. ;
Ostrovnaya, Irina ;
Seshan, Venkatraman E. ;
Morrogh, Mary ;
Giri, Dilip ;
Olvera, Narciso ;
De Brot, Marina ;
Morrow, Monica ;
Begg, Colin B. ;
King, Tari A. .
BREAST CANCER RESEARCH, 2012, 14 (04)
[3]  
[Anonymous], 2003, WHO CLASSIFICATION T
[4]   Histologic Associations and Long-term Cancer Risk in Columnar Cell Lesions of the Breast A Retrospective Cohort and a Nested Case-Control Study [J].
Boulos, Fouad I. ;
Dupont, William D. ;
Simpson, Jean F. ;
Schuyler, Peggy A. ;
Sanders, Melinda E. ;
Freudenthal, Marcia E. ;
Page, David L. .
CANCER, 2008, 113 (09) :2415-2421
[5]  
Dabbs DJ, 2013, AM J SURG PATHOL, V37, pE1, DOI 10.1097/PAS.0b013e3182918a2b
[6]   Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology [J].
Ellis, Ian O. .
MODERN PATHOLOGY, 2010, 23 :S1-S7
[7]  
Elston C.W., 1998, BREAST, V3rd
[8]   Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast [J].
Elston, CW ;
Sloane, JP ;
Amendoeira, I ;
Apostolikas, N ;
Bellocq, JP ;
Bianchi, S ;
Boecker, W ;
Bussolati, G ;
Coleman, D ;
Connolly, CE ;
Dervan, P ;
Drijkoningen, M ;
Eusebi, V ;
Faverly, D ;
Holland, R ;
Jacquemier, J ;
Lacerda, M ;
Martinez-Penuela, J ;
de Miguel, C ;
Moss, S ;
Munt, C ;
Peterse, JL ;
Rank, F ;
Reiner, A ;
Sylvan, M ;
Wells, CA ;
Zafrani, B .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (14) :1769-1772
[9]   PLEOMORPHIC LOBULAR CARCINOMA OF THE BREAST - AN AGGRESSIVE TUMOR SHOWING APOCRINE DIFFERENTIATION [J].
EUSEBI, V ;
MAGALHAES, F ;
AZZOPARDI, JG .
HUMAN PATHOLOGY, 1992, 23 (06) :655-662
[10]   Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Redmond, CK ;
Kavanah, M ;
Cronin, WM ;
Vogel, V ;
Robidoux, A ;
Dimitrov, N ;
Atkins, J ;
Daly, M ;
Wieand, S ;
Tan-Chiu, E ;
Ford, L ;
Wolmark, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388